CLINICAL_TRIALS
trial_result
· 2012-06-25
Clinical Trial Update: The Effect of Bevacizumab (Avastin) on Pterygium [Phase 2]
Summary
A Phase 2 clinical trial evaluated bevacizumab (Avastin) for the treatment of pterygium; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Pterygium | Phase 2 | Status: COMPLETED | Results posted: 2012-06-25